Longevity Health Holdings, Inc. (XAGE): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$7.03M
Year ended 2025-12-31
-$5.73M
Trailing 12 months to 2026-06-30
2022-12-31: -$5.41M2023-12-31: -$5.85M2024-12-31: -$4.92M2025-12-31: -$7.03M-$7.03M
2022-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$7.03Mn/m2026-03-31, From 2025-01-01
2024-12-31-$4.92Mn/m2026-03-31, From 2024-01-01
2023-12-31-$5.85Mn/m2025-06-17, From 2023-01-01
2022-12-31-$5.41Mn/a2024-04-01, From 2022-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Longevity Health Holdings, Inc. (XAGE)2025-12-31-$7.03Mn/m
Park Ha Biological Technology Co., Ltd. (BYAH)2025-10-31-$24.04Mn/m
Meiwu Technology Co Ltd (WNW)2025-12-31-$5.90Mn/m
Stepan Co (SCL)2025-12-31$204.59M+12.0%
Church & Dwight Co Inc (CHD)2025-12-31$1.32B+26.6%
Procter & Gamble Co (PG)2026-06-30$22.91B-1.7%

Compare XAGE, BYAH, WNW, SCL side by side · Screen every company in Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics ↗